INTS8

INTS8 is a subunit of the Integrator complex that controls RNA Polymerase II promoter-proximal transcription by gating the transition from pausing into productive elongation (PMID:32966759, PMID:39667934). It is required for the association of the Integrator complex with protein phosphatase 2A (PP2A), and Integrator-bound PP2A dephosphorylates the RNA Pol II C-terminal domain and Spt5 to prevent the switch to productive elongation (PMID:32966759); the N-terminal domain of INTS8 is necessary for this phosphatase activity, as an N-terminally truncated INTS8 causes genome-wide RNA Pol II hyperphosphorylation (PMID:37831607). Functionally, INTS8 acts as a quality-control gatekeeper that restrains the release of excess, transcriptionally incompetent RNA Pol II into early elongation, working in parallel with the CRL3ARMC5 ubiquitin ligase (PMID:39667934). Beyond pause regulation, INTS8 is required for Integrator complex stability and for 3'-end maturation of UsnRNAs, and biallelic INTS8 mutations in humans disrupt these processes and broadly perturb gene expression and RNA processing (PMID:28542170). In neural development, INTS8 attenuates RNA Pol II pause-release to suppress precocious neuronal gene activation and sustain the progenitor pool, functioning genetically upstream of the transcription factor earmuff to prevent intermediate neural progenitor dedifferentiation in Drosophila (PMID:31018143). In hepatocellular carcinoma cells, INTS8 promotes epithelial-to-mesenchymal transition and invasion upstream of TGF-β/SMAD4 signaling (PMID:30881114).

1. 2017 High

   Establishing that INTS8 is functionally required within the Integrator complex—the question was whether INTS8 loss has a discrete molecular consequence—showed it is needed for complex stability and UsnRNA 3'-end maturation in humans.

   Evidence Patient-derived cells with biallelic INTS8 mutations, northern/RT-PCR for unprocessed UsnRNA, protein stability assays, and genome editing in a neural differentiation model

   PMID:28542170

   Open questions at the time

   • Did not resolve the molecular mechanism by which INTS8 stabilizes the complex
   • Connection to RNA Pol II pausing not yet established
   • Tissue-specific consequences of UsnRNA misprocessing unaddressed
2. 2019 High

   Placing INTS8 within a developmental pathway—whether Integrator function has cell-fate consequences—showed it suppresses intermediate neural progenitor dedifferentiation genetically upstream of earmuff.

   Evidence Drosophila loss-of-function genetics, INP-specific RNAi, DamID chromatin profiling, and intS8 × erm genetic epistasis

   PMID:31018143

   Open questions at the time

   • Did not define the transcriptional mechanism linking INTS8 to erm regulation
   • Whether the role depends on UsnRNA processing or Pol II control not distinguished
3. 2019 Medium

   Testing INTS8 in a disease context—whether it influences cancer cell behavior—showed it promotes EMT and invasion upstream of TGF-β/SMAD4 signaling.

   Evidence shRNA knockdown in HCC lines, migration/invasion/transwell and in vivo metastasis assays, EMT-marker analysis, and TGF-β1 rescue

   PMID:30881114

   Open questions at the time

   • Mechanistic link between Integrator/Pol II control and SMAD4 levels not established
   • Whether the effect is Integrator-dependent or an INTS8 moonlighting function unresolved
4. 2020 High

   Defining the biochemical mechanism of Integrator repression—how it terminates paused Pol II—showed INTS8 is required to recruit PP2A, which dephosphorylates the Pol II CTD and Spt5 to block productive elongation.

   Evidence INTS8 knockdown, reciprocal co-immunoprecipitation, CTD/Spt5 phosphorylation assays, and transcriptional readouts

   PMID:32966759

   Open questions at the time

   • Structural basis of the INTS8–PP2A interface not determined
   • Which INTS8 domain mediates PP2A association not yet mapped
5. 2023 Medium

   Mapping the structural requirement for phosphatase activity—which part of INTS8 is needed—showed the N-terminal domain is essential, as INTS8-ΔN causes genome-wide Pol II hyperphosphorylation.

   Evidence dTAG-mediated degradation of endogenous INTS8 with ectopic INTS8-ΔN expression and RNA Pol II phosphorylation readouts

   PMID:37831607

   Open questions at the time

   • Protocol paper with limited mechanistic depth
   • Does not pinpoint residues or define how the N-terminus enables PP2A activity
6. 2024 High

   Resolving INTS8's role in Pol II quantity/quality control—whether it gates excess polymerase—showed it prevents release of transcriptionally incompetent Pol II into gene bodies, acting in parallel with CRL3ARMC5.

   Evidence ARMC5/INTS8 double loss-of-function, cell growth assays, RNA Pol II ChIP/occupancy, and identification of elongation-incompetent complexes

   PMID:39667934

   Open questions at the time

   • How Integrator distinguishes competent from incompetent Pol II not defined
   • Direct biochemical link between INTS8 and CRL3ARMC5 pathways not established
7. 2024 Medium

   Connecting INTS8 pause-control to neural progenitor maintenance—whether Integrator attenuation of pause-release governs cortical development—showed a complex-disrupting INTS8 variant causes global nascent transcription increase and precocious neuronal gene expression, rescued by BRD4 degradation.

   Evidence Patient-derived neural progenitor cells, nascent transcription assays, BRD4 targeted degradation rescue, and cortical differentiation assays (preprint)

   Open questions at the time

   • Preprint, not yet peer-reviewed
   • Whether premature differentiation arises purely from pause-release defects versus UsnRNA processing not disentangled

• How INTS8 mechanistically links Integrator-mediated Pol II pause control to its developmental and oncogenic phenotypes (earmuff regulation, SMAD4 signaling) remains unresolved.
• No structural model of INTS8 within Integrator or of the PP2A interface
• Mechanism connecting transcription control to SMAD4 downregulation undefined
• Whether developmental phenotypes reflect Pol II pausing, UsnRNA maturation, or both unresolved